The world of motorsports was shaken with the heartbreaking loss of Lizzy Musi, the 33-year-old star of Street Outlaws: No Prep Kings, who passed away after a valiant battle with stage IV breast cancer ...

TV personality Clea Shearer is sharing her journey with breast cancer. Shearer talks about how her latest project intersects with her breast cancer experience. Advances in breast cancer treatment ...

Black women are about 40% more likely to die of breast cancer than White women, but new research is showing this applies to all forms of the disease — and examines why. In the study, published ...

This is the man who literally has my fate in his hands, I thought, as the surgical oncologist, Dr. Brian Pinchuk, at North York General Hospital’s breast cancer program, called me into the ...

Two studies have shown for the first time that breastfeeding after treatment for breast cancer does not increase a woman's recurrence risk. And, as other studies at the meeting showed ...

Women with early stage breast cancer may now take Kisqali, a medication already approved for advanced disease, following the U.S. Food and Drug Administration's expanded approval of the treatment ...

WHY? WELL, BECAUSE THE RISK OF BREAST CANCER IS HIGHER FOR WOMEN WITH DENSE BREASTS. HERE TO BREAK IT ALL DOWN FOR US IS DOCTOR JAMIE SLOTKIN, A BREAST SURGEON AT WELLSPAN HEALTH. THANK YOU SO ...

Sept. 18, 2024 – People with a common type of early-stage breast cancer may now take another drug called Kisqali that has been shown to significantly reduce the risk of cancer recurrence ...

Black women have a higher risk of dying from any type of breast cancer than White women, a new review finds. Overall, the increased survival risk for Black women ranges from 17% to 50% ...

Parsons: It makes sense when we think about our staging system for early-stage breast cancer that includes, from an anatomic perspective, smaller cancers. Patients with smaller cancers do better ...

Kisqali, a key targeted therapy for breast cancer from Novartis, until now has been indicated only for patients with metastatic disease. But on Tuesday, the Food and Drug Administration approved ...